153 related articles for article (PubMed ID: 23568616)
1. New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients.
Pilcer G; Rosière R; Traina K; Sebti T; Vanderbist F; Amighi K
J Pharm Sci; 2013 Jun; 102(6):1836-1846. PubMed ID: 23568616
[TBL] [Abstract][Full Text] [Related]
2. Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis.
Pilcer G; De Bueger V; Traina K; Traore H; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2013 Jul; 451(1-2):112-20. PubMed ID: 23643509
[TBL] [Abstract][Full Text] [Related]
3. Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.
Miller DP; Tan T; Tarara TE; Nakamura J; Malcolmson RJ; Weers JG
Mol Pharm; 2015 Aug; 12(8):2582-93. PubMed ID: 26052676
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
[TBL] [Abstract][Full Text] [Related]
5. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
Pilcer G; Vanderbist F; Amighi K
J Pharm Sci; 2009 Apr; 98(4):1463-75. PubMed ID: 18752304
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
7. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
8. Novel combination proliposomes containing tobramycin and clarithromycin effective against Pseudomonas aeruginosa biofilms.
Ye T; Sun S; Sugianto TD; Tang P; Parumasivam T; Chang YK; Astudillo A; Wang S; Chan HK
Int J Pharm; 2018 Dec; 552(1-2):130-138. PubMed ID: 30267753
[TBL] [Abstract][Full Text] [Related]
9. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
10. Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis.
Porsio B; Cusimano MG; Schillaci D; Craparo EF; Giammona G; Cavallaro G
Biomacromolecules; 2017 Dec; 18(12):3924-3935. PubMed ID: 29111673
[TBL] [Abstract][Full Text] [Related]
11. The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family.
Hoppentocht M; Akkerman OW; Hagedoorn P; Frijlink HW; de Boer AH
Eur J Pharm Biopharm; 2015 Feb; 90():8-15. PubMed ID: 25615881
[TBL] [Abstract][Full Text] [Related]
12. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
[TBL] [Abstract][Full Text] [Related]
13. Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation.
Pilcer G; Sebti T; Amighi K
Pharm Res; 2006 May; 23(5):931-40. PubMed ID: 16715383
[TBL] [Abstract][Full Text] [Related]
14. Clarithromycin and N-acetylcysteine co-spray-dried powders for pulmonary drug delivery: A focus on drug solubility.
Manniello MD; Del Gaudio P; Aquino RP; Russo P
Int J Pharm; 2017 Nov; 533(2):463-469. PubMed ID: 28377314
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency.
Parlati C; Colombo P; Buttini F; Young PM; Adi H; Ammit AJ; Traini D
Pharm Res; 2009 May; 26(5):1084-92. PubMed ID: 19184617
[TBL] [Abstract][Full Text] [Related]
16. Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.
Costabile G; d'Angelo I; Rampioni G; Bondì R; Pompili B; Ascenzioni F; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Miro A; Quaglia F; Imperi F; Leoni L; Ungaro F
Mol Pharm; 2015 Aug; 12(8):2604-17. PubMed ID: 25974285
[TBL] [Abstract][Full Text] [Related]
17. Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt.
Manniello MD; Del Gaudio P; Porta A; Aquino RP; Russo P
Eur J Pharm Biopharm; 2016 Jul; 104():1-6. PubMed ID: 27106605
[TBL] [Abstract][Full Text] [Related]
18. Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology.
Geller DE; Weers J; Heuerding S
J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):175-82. PubMed ID: 21395432
[TBL] [Abstract][Full Text] [Related]
19. Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.
Vazquez-Espinosa E; Marcos C; Alonso T; Giron RM; Gomez-Punter RM; Garcia-Castillo E; Zamora E; Cisneros C; Garcia J; Valenzuela C; Ancochea J
Expert Rev Anti Infect Ther; 2016; 14(1):9-17. PubMed ID: 26559549
[TBL] [Abstract][Full Text] [Related]
20. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
